A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale
- 30 September 2004
- journal article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 57 (9), 898-910
- https://doi.org/10.1016/j.jclinepi.2004.01.012
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Effects on quality of life of combined trastuzumab and chemotherapy in women with metastatic breast cancerJournal of Clinical Oncology, 2002
- Primary Care for Survivors of Breast CancerThe New England Journal of Medicine, 2000
- Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.Journal of Clinical Oncology, 1997
- Psychosocial sequelae of breast cancer and its treatmentAnnals of Behavioral Medicine, 1996
- Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.Journal of Clinical Oncology, 1996
- Quality of Life in Cancer: Definition, Purpose, and Method of MeasurementCancer Investigation, 1993
- Quality-of-Life Assessment in Cancer Clinical Trials: A Status ReportJNCI Journal of the National Cancer Institute, 1992
- Assessing the quality of life—a study in newly-diagnosed breast cancer patientsJournal of Clinical Epidemiology, 1990
- Improving the Quality of Life during Chemotherapy for Advanced Breast CancerThe New England Journal of Medicine, 1987
- Psychosocial correlates of breast cancer and its treatments.Psychological Bulletin, 1980